ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NDRA ENDRA Life Sciences Inc

Trading 11-15 12:51:09 EST

4.55

-0.75

-14.15%

High5.33	Low4.40	Vol105.58K
Open5.24	D1 Closing5.30	Amplitude17.55%
Mkt Cap2.42M	Tradable Cap2.36M	Total Shares531.19K
T/O512.03K	T/O Rate20.37%	Tradable Shares518.19K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NDRA","market":"US","secType":"STK","nameCN":"ENDRA Life Sciences Inc","latestPrice":4.55,"timestamp":1731693044464,"preClose":5.3,"halted":0,"volume":105581,"delay":0,"floatShares":518194,"shares":531189,"eps":-1233.3685,"marketStatus":"Trading","change":-0.75,"latestTime":"11-15 12:51:09 EST","open":5.24,"high":5.33,"low":4.4,"amount":512032.19529630005,"amplitude":0.175472,"askPrice":4.64,"askSize":13,"bidPrice":4.5,"bidSize":7,"shortable":0,"etf":0,"ttmEps":-1233.3685,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1731704400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.3,"preHourTrading":{"tag":"盘前","latestPrice":5.49,"preClose":5.3,"latestTime":"09:26 EST","volume":267,"amount":1457.5325211000002,"timestamp":1731680777671},"postHourTrading":{"tag":"盘后","latestPrice":5.31,"preClose":5.29,"latestTime":"19:59 EST","volume":2299,"amount":12199.0186,"timestamp":1731632386155},"volumeRatio":0.822367},"requestUrl":"/m/hq/s/NDRA/wiki","defaultTab":"wiki","newsList":[{"id":"2483137413","title":"ENDRA Life Sciences Q3 EPS $(9.54)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483137413","media":"Benzinga","labels":["express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2483137413?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:25","pubTimestamp":1731680707,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Q3 EPS $(9.54)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/42009503/endra-life-sciences-q3-eps-9-54","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ENDRA Life Sciences Q3 EPS $(9.54)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA"],"gpt_icon":0},{"id":"2483830522","title":"ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483830522","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483830522?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:53","pubTimestamp":1731686011,"startTime":"0","endTime":"0","summary":"* ENDRA Life Sciences Inc    reported a quarterly adjusted loss of $9.54 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-700.00","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA"],"gpt_icon":0},{"id":"2483921374","title":"ENDRA Life Sciences Inc: Qtrly Loss per Share $9.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2483921374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483921374?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:24","pubTimestamp":1731680640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA81F3QN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NDRA"],"gpt_icon":0},{"id":"2483374604","title":"ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483374604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483374604?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:24","pubTimestamp":1731680640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA81F3QN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NDRA","BK4082"],"gpt_icon":0},{"id":"2483837493","title":"Press Release: ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483837493","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483837493?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:24","pubTimestamp":1731680640,"startTime":"0","endTime":"0","summary":"Company accelerated enrollment in global multisite pilot study and significantly reduced operating expenses while refocusing resources to clinical and regulatory deliverables. ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound , today reported financial results for the three and nine months ended September 30, 2024 and provided a business update.Highlights from the third quarter and recent weeks include:. Developed data analysis features for TAEUS platform by introducing new. models rooted in artificial intelligence , machine learning  and. deep learning . As part of its continuous technology improvement of. the TAEUS system, ENDRA made advancements in developing and testing new. features and capabilities that leverage AI, ML and DL models and. Accelerated subject recruitment at clinical evaluation sites. Clinical. assess TAEUS' liver fat measurement capabilities against the. the TAEUS system for metabolic disease management. In addition, the. Activated a TAEUS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMI","BK4082","BK4232","BK4157","NDRA","R","ML","BK4166","BK4022"],"gpt_icon":1},{"id":"2482270135","title":"Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2482270135","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482270135?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:00","pubTimestamp":1731416400,"startTime":"0","endTime":"0","summary":"ANN ARBOR, Mich., November 12, 2024----ENDRA Life Sciences Inc. , an innovator of Thermo Acoustic Enhanced UltraSound , today announced the acceptance of a poster titled \"Noninvasive assessment of steatotic liver disease in individuals with class 2 and class 3 obesity\" for presentation at The Liver Meeting 2024, hosted by the American Association for the Study of Liver Disease , taking place November 15-19 in San Diego.All statements in this press release that are not based on historical fact are \"forward-looking statements\" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of terms such as \"approximate,\" \"anticipate,\" \"attempt,\" \"believe,\" \"could,\" \"es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-highlighting-endra-life-sciences-130000787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4157","NDRA","BK4082","BMI"],"gpt_icon":1},{"id":"2481483623","title":"ENDRA Life Sciences Inc    expected to post a loss of $62.30 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483623","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481483623?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:48","pubTimestamp":1731080912,"startTime":"0","endTime":"0","summary":"* ENDRA Life Sciences Inc     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending September 30 2024   *    * LSEG's mean analys","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ENDRA Life Sciences Inc    expected to post a loss of $62.30 a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA"],"gpt_icon":1},{"id":"2481899594","title":"ENDRA Life Sciences Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481899594?lang=en_us&edition=fundamental","pubTime":"2024-11-07 08:51","pubTimestamp":1730940703,"startTime":"0","endTime":"0","summary":"19:50 EST ENDRA Life Sciences (NDRA) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-inc-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-inc-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDRA","BK4082"],"gpt_icon":0},{"id":"2481609382","title":"ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2481609382","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481609382?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898000,"startTime":"0","endTime":"0","summary":"Global Intellectual Property Portfolio Now Includes 82 Issued Patents. The ‘282 patent relates to a novel method and system for monitoring tissue ablation during minimally invasive thermal surgical interventions by utilizing ENDRA’s TAEUS system. It is related to ENDRA’s U.S. patent US11,051,883 enabling integration with existing ablation systems. ENDRA expects its method and system to be applicable to minimally invasive microwave and radiofrequency thermal ablation procedures, which continue to grow globally as a less painful alternative with shorter recovery times compared with open surgical procedures.\"This issued patent, our 17th in Europe, supports ENDRA’s strategy to develop optimized hybrid ultrasound and thermoacoustic imaging systems and to broaden the potential applications for our TAEUS platform technology in areas with unmet clinical needs,\" stated ENDRA's Chief Executive Officer Alexander Tokman. \"We continue to enhance our intellectual property portfolio to protect our te","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/endra-life-sciences-further-strengthens-130000020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","NDRA"],"gpt_icon":1},{"id":"2477041363","title":"ENDRA Life Sciences Shares Soar After Launch of Postmarket Trial for TAEUS Liver System","url":"https://stock-news.laohu8.com/highlight/detail?id=2477041363","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477041363?lang=en_us&edition=fundamental","pubTime":"2024-10-23 01:23","pubTimestamp":1729617827,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences  shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat measurement capabilities of its TAEUS system.The company said a first patient was scanned with the TAEUS system in the study, which is designed to assess the system's utility for managing metabolic disease.ENDRA said it expects the collaboration with LMU researchers to augment clinical data and support the company's de novo submission to the US Food and Drug Administration by mid-2025.Price: 0.49, Change: +0.27, Percent Change: +124.43","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NDRA","BK4082"],"gpt_icon":1},{"id":"2477316337","title":"BRIEF-Endra Life Sciences Activates Taeus System To Initiate Clinical Study At Lmu University Hospital In Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2477316337","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477316337?lang=en_us&edition=fundamental","pubTime":"2024-10-22 21:44","pubTimestamp":1729604695,"startTime":"0","endTime":"0","summary":"Oct 22 (Reuters) - ENDRA Life Sciences Inc   :   * ENDRA LIFE SCIENCES ACTIVATES TAEUS SYSTEM TO INITIATE CLINICAL STUDY AT LMU UNIVERSITY HOSPITAL IN GERMANYSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"gpt_icon":0},{"id":"2477633872","title":"ENDRA Life Sciences Activates Taeus System to Initiate Clinical Study at Lmu University Hospital in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2477633872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477633872?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUA2R6RGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NDRA"],"gpt_icon":0},{"id":"2477335418","title":"ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2477335418","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477335418?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598400,"startTime":"0","endTime":"0","summary":"Scans first patient in post-CE mark clinical study with Munich’s center of excellence in Europe’s largest healthcare market. LMU University Hospital is conducting a post market clinical study to collect data to assess TAEUS’ liver fat measurement capabilities against the gold standard MRI-PDFF test. This study is intended to collect real-world clinical evidence to further establish the utility of the TAEUS system for metabolic disease management. LMU researchers plan to present the findings of the study at future medical congresses followed by a peer-reviewed publication.ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound , a ground-breaking technology that characterizes tissue similar to an MRI, but at 1/40th the cost and at the point of patient care. TAEUS is initially focused on the non-invasive assessment of fatty tissue in the liver. Steatotic liver disease  is a chronic liver disease spectrum that affects over two billion people globally, and for which there","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/endra-life-sciences-activates-taeus-120000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","WRD","NDRA"],"gpt_icon":0},{"id":"2463580410","title":"ENDRA Life Sciences Strives for Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2463580410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463580410?lang=en_us&edition=fundamental","pubTime":"2024-08-29 05:28","pubTimestamp":1724880511,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences (NDRA) just unveiled an announcement. ENDRA Life Sciences Inc. has announced that they’ve received additional time from a Nasda...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/endra-life-sciences-strives-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/endra-life-sciences-strives-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","QID","QLD","LU2095319765.USD","MNQmain","LU2210149790.SGD","NDAQ","SQQQ","NDRA",".IXIC","IE00BKPKM429.USD","LU2210150020.SGD","TQQQ","PSQ","NQmain","BK4082","BK4585","BK4588"],"gpt_icon":1},{"id":"2463419031","title":"ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2463419031","media":"seekingalpha","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463419031?lang=en_us&edition=fundamental","pubTime":"2024-08-29 04:28","pubTimestamp":1724876892,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences  on Wednesday said it was notified by Nasdaq that the Nasdaq Hearings Panel has granted the company’s request for an extension through November 20 to evidence compliance with the $1.00 bid price requirement for continued listing. NDRA  +11.11% after hours to  $0.455.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4144776-endra-life-sciences-granted-extension-to-regain-compliance-with-nasdaq-continued-listing-requirements","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MNQmain","PSQ","NDRA","BK4082","QID","BK4112","LU2095319765.USD","TQQQ","LU2210149790.SGD","LU2210150020.SGD","QLD","SQQQ","IE00BKPKM429.USD","BK4585","NQmain","BK4588","NDAQ",".IXIC"],"gpt_icon":1},{"id":"2463411627","title":"ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2463411627","media":"Business Wire","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463411627?lang=en_us&edition=fundamental","pubTime":"2024-08-29 04:17","pubTimestamp":1724876220,"startTime":"0","endTime":"0","summary":"ANN ARBOR, Mich., August 28, 2024----ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound , today announced that on August 27, 2024, the Company was notified by The Nasdaq Stock Market LLC  that the Nasdaq Hearings Panel  has granted the Company’s request for an extension through November 20, 2024, to evidence compliance with the $1.00 bid price requirement for continued listing on The Nasdaq Capital Market.To regain compliance with the bid price requirement, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading sessions on or before November 20, 2024. The Company is considering all available options to timely evidence compliance with the terms of the Panel’s decision.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/endra-life-sciences-granted-extension-201700503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","LU2210149790.SGD","BK4112","LU2210150020.SGD","MNQmain","TQQQ","LU2095319765.USD","QID","NDRA","BK4082","QLD","PSQ","NDAQ","SQQQ","BK4588",".IXIC","BK4585","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2461873523","title":"ENDRA Life Sciences Discusses Quarterly Results in Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2461873523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461873523?lang=en_us&edition=fundamental","pubTime":"2024-08-24 04:28","pubTimestamp":1724444930,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ENDRA Life Sciences (NDRA). The Company recently held a conference call to discuss its quarterly financial perf...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/endra-life-sciences-discusses-quarterly-results-in-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/endra-life-sciences-discusses-quarterly-results-in-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDRA","BK4082"],"gpt_icon":0},{"id":"2461373377","title":"Endra Life Sciences GAAP EPS of -$0.08 misses by $0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2461373377","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461373377?lang=en_us&edition=fundamental","pubTime":"2024-08-23 04:18","pubTimestamp":1724357910,"startTime":"0","endTime":"0","summary":"Endra Life Sciences press release  (NASDAQ:NDRA): Q2  GAAP EPS of -$0.08  misses by $0.01.\nCash and cash equivalents were $6.4 million as of June 30, 2024. In June 2024, the Company raised approximately $7.3 million in net proceeds through a public offering.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4143070-endra-life-sciences-gaap-eps-of-0_08-misses-0_01","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["TQQQ","NQmain","BK4082","QLD","MNQmain","NDRA","QID",".IXIC","PSQ","SQQQ"],"gpt_icon":1},{"id":"2461378174","title":"ENDRA Life Sciences Q2 2024 GAAP EPS $(0.08) Misses $(0.04) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2461378174","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461378174?lang=en_us&edition=fundamental","pubTime":"2024-08-23 04:15","pubTimestamp":1724357703,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.04) by 100 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/08/40516573/endra-life-sciences-q2-2024-gaap-eps-0-08-misses-0-04-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ENDRA Life Sciences Q2 2024 GAAP EPS $(0.08) Misses $(0.04) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA"],"gpt_icon":0},{"id":"2461781803","title":"ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2461781803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461781803?lang=en_us&edition=fundamental","pubTime":"2024-08-23 04:14","pubTimestamp":1724357640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240822:nTUACCFWM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NDRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.endrainc.com","stockEarnings":[{"period":"1week","weight":-0.1064},{"period":"1month","weight":-0.2768},{"period":"3month","weight":-0.925},{"period":"6month","weight":-0.9902},{"period":"1year","weight":-0.9969},{"period":"ytd","weight":-0.9986}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":0.123772},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.074543},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.203615},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.181635},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.093011},{"month":6,"riseRate":0.714286,"avgChangeRate":0.030342},{"month":7,"riseRate":0.25,"avgChangeRate":-0.069103},{"month":8,"riseRate":0.5,"avgChangeRate":-0.108988},{"month":9,"riseRate":0.25,"avgChangeRate":-0.112503},{"month":10,"riseRate":0.25,"avgChangeRate":0.028524},{"month":11,"riseRate":0.375,"avgChangeRate":-0.106217},{"month":12,"riseRate":0.571429,"avgChangeRate":0.246735}],"exchange":"NASDAQ","name":"ENDRA Life Sciences Inc","nameEN":"ENDRA Life Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ENDRA Life Sciences Inc(NDRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ENDRA Life Sciences Inc,NDRA,ENDRA Life Sciences Inc股票,ENDRA Life Sciences Inc股票老虎,ENDRA Life Sciences Inc股票老虎国际,ENDRA Life Sciences Inc行情,ENDRA Life Sciences Inc股票行情,ENDRA Life Sciences Inc股价,ENDRA Life Sciences Inc股市,ENDRA Life Sciences Inc股票价格,ENDRA Life Sciences Inc股票交易,ENDRA Life Sciences Inc股票购买,ENDRA Life Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ENDRA Life Sciences Inc(NDRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}